CD274 and melanoma: Despite this, recent studies have shown that elevated expression of PD-L1 in tumors correlates with better response rate (RR), progression-free survival (PFS), and overall survival (OS) to anti-PD-1-directed therapy in melanoma and other types of cancer15.